Baader Bank Aktiengesellschaft Raises Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Baader Bank Aktiengesellschaft raised its stake in shares of Zoetis Inc. (NYSE:ZTS) by 20.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,373 shares of the company’s stock after purchasing an additional 400 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Zoetis were worth $387,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Algert Global LLC raised its stake in shares of Zoetis by 29.5% during the second quarter. Algert Global LLC now owns 1,924 shares of the company’s stock worth $334,000 after acquiring an additional 438 shares in the last quarter. Quarry LP raised its position in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after purchasing an additional 153 shares during the period. Truist Financial Corp lifted its stake in Zoetis by 1.5% in the second quarter. Truist Financial Corp now owns 169,202 shares of the company’s stock worth $29,333,000 after purchasing an additional 2,557 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Zoetis during the second quarter valued at about $19,525,000. Finally, Heritage Wealth Management Inc. purchased a new position in shares of Zoetis in the second quarter worth about $624,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the topic of several recent research reports. Leerink Partners started coverage on Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 price target on the stock. Morgan Stanley decreased their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research note on Wednesday. UBS Group initiated coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price target for the company. Stifel Nicolaus decreased their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. raised their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $215.00.

Zoetis Stock Performance

Shares of ZTS stock opened at $172.61 on Friday. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53. The stock has a market cap of $77.88 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 2.70 and a beta of 0.89. The company’s fifty day moving average price is $169.82 and its 200-day moving average price is $179.59. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same period last year, the company earned $1.36 earnings per share. The company’s revenue was up 11.6% on a year-over-year basis. On average, equities analysts expect that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 1.16%. This is a boost from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s payout ratio is presently 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.